Violation Tracker Parent Company Summary
Parent Company Name:
Viatris
Ownership Structure:
publicly traded (ticker symbol VTRS)
Headquartered in:
Pennsylvania
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
Penalty total since 2000:
$1,186,843,370
Number of records:
47
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
|---|---|---|
| government-contracting-related offenses | $1,011,761,157 | 31 |
| consumer-protection-related offenses | $100,250,000 | 2 |
| competition-related offenses | $43,300,000 | 4 |
| financial offenses | $30,000,000 | 1 |
| environment-related offenses | $1,057,213 | 7 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
|---|---|---|
| False Claims Act and related | $1,011,761,157 | 31 |
| consumer protection violation | $100,250,000 | 2 |
| kickbacks and bribery | $34,700,000 | 2 |
| investor protection violation | $30,000,000 | 1 |
| price-fixing or anti-competitive practices | $8,000,000 | 1 |
Notes:
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links:
For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year | Agency |
Penalty Amount |
|---|---|---|---|---|
| Mylan Inc. | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
| Mylan Inc. | False Claims Act and related | 2017 | MULTI-AG | (*) $465,000,000 |
| Dey Inc. | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
| Mylan Pharmaceuticals and UDL Laboratories | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
| Mylan Pharmaceuticals, Inc. | False Claims Act and related | 2009 | MULTI-AG | (*) $118,000,000 |
| Mylan Laboratories et al. | price-fixing or anti-competitive practices | 2000 | MULTI-AG | (*) $108,000,000 |
| Mylan Laboratories, Inc. | consumer protection violation | 2000 | FTC | $100,000,000 |
| Mylan N.V. | investor protection violation | 2019 | SEC | $30,000,000 |
| Pharmacia Corporation | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
| Mylan Laboratories Inc. | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
| Pharmacia & Upjohn Company Inc. | kickbacks and bribery | 2007 | USAO | $19,700,000 |
| Pharmacia Corporation | False Claims Act and related | 2019 | IL-AG | $18,960,210 |
| Dey, Inc. | False Claims Act and related | 2003 | DOJ_CIVIL | $18,500,000 |
| Pharmacia & Upjohn Company LLC | kickbacks and bribery | 2007 | USAO | $15,000,000 |
| Dey, Inc. | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
| Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
| Dey L.P. | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
| Dey Inc. | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
| Dey Labs | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
| Dey, Inc. | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
| Dey | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
| Dey Inc. | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
| Dey, Inc. | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
| Mylan Inc. | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
| Dey Inc. | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
| Pharmacia Corporation | False Claims Act and related | 2011 | NY-AG | $2,500,000 |
| Dey Pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
| Dey, Inc. | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
| Dey, Inc. | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
| Dey, Inc. | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
| Dey, Inc. | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
| Dey Inc. | False Claims Act and related | 2004 | WV-AG | $850,000 |
| Pharmacia & Upjohn Company | environmental violation | 2005 | EPA | $676,250 |
| Dey, Inc. | False Claims Act and related | 2007 | NV-AG | $670,000 |
| Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | False Claims Act and related | 2012 | ID-AG | $625,000 |
| Dey, Inc. | fraud | 2004 | AR-AG | $600,000 |
| Pharmacia Corp. | False Claims Act and related | 2009 | OH-AG | $400,000 |
| Mylan Specialty L.P. | consumer protection violation | 2013 | OR-AG | $250,000 |
| Mylan Specialty, L.P. | off-label or unapproved promotion of medical products | 2013 | MA-AG | $250,000 |
| Mylan | wage and hour violation | 2014 | private lawsuit-federal | $225,000 |
| PHARMACIA/SOLUTIA | environmental violation | 2007 | IL-ENV | $210,000 |
| Dey LP | False Claims Act and related | 2007 | MT-AG | $198,000 |
| PHARMACIA CORPORATION, et al. | environmental violation | 2009 | IL-ENV | $96,000 |
| Pharmacia and Upjohn Company LLC | environmental violation | 2017 | EPA | $34,170 |
| PHARMACIA & UPJOHN CARIBE | environmental violation | 2001 | EPA | $27,168 |
| PHARMACIA CORP | environmental violation | 2002 | NJ-ENV | $8,625 |
| PHARMACIA & UPJOHN COMPANY, LLC. | environmental violation | 2004 | EPA | $5,000 |
